Association between comorbidities and left and right atrial dysfunction in patients with paroxysmal atrial fibrillation: Analysis of AF-RISK

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,02 MB, PDF-dokument

  • Manouk J.W. van Mourik
  • Vicente Artola Arita
  • Aurore Lyon
  • Joost Lumens
  • Ruben R. De With
  • Joost P. van Melle
  • Ulrich Schotten
  • Sebastiaan C.A.M. Bekkers
  • Harry J.G.M. Crijns
  • Isabelle C. Van Gelder
  • Michiel Rienstra
  • Dr Linz, Dominik Karl

Background: To identify the association between comorbidities and left atrial (LA) and right atrial (RA) function in patients with paroxysmal atrial fibrillation (AF). Methods: This is a cross-sectional study. Speckle-tracking echocardiography was performed in 344 patients with paroxysmal AF at baseline, and available in 298 patients after 1-year follow-up. The number of comorbidities (hypertension, diabetes mellitus, coronary artery disease, body mass index > 25 kg/m2, age > 65 years, moderate to severe mitral valve regurgitation and kidney dysfunction (estimated glomerular filtration rate < 60 ml/min/1.73 m2)) was determined and the association with atrial strain was tested. Results: Mean age of the patients was 58 (SD 12) years and 137 patients were women (40%). Patients with a higher number of comorbidities had larger LA volumes (p for trend <0.001), and had a decrease in all strain phases from the LA and RA, except for the RA contraction phase (p for trend 0.47). A higher number of comorbidities was associated with LA reservoir and conduit strain decrease independently of LA volume (p < 0.001, p < 0.001 respectively). Patients with 1–2 comorbidities, but not patients with 3 or more comorbidities, showed a further progression of impaired LA and RA function in almost all atrial strain phases at 14 [13–17] months follow-up. Conclusions: In patients with paroxysmal AF, individual and combined comorbidities are related to lower LA and RA strain. In patients with few comorbidities, impairment in atrial function progresses during one year of follow-up. Whether comorbidity management prevents or reverses decrease in atrial function warrants further study.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiology
Vol/bind360
Sider (fra-til)29-35
ISSN0167-5273
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
We acknowledge the support from the Netherlands Cardiovascular Research Initiativ e: an initiative with support of the Dutch Heart Foundation , CVON 2014-9 : Reappraisal of Atrial Fibrillation: interaction between hyperCoagulability, Electrical remodelling, and Vascular destabilisation in the progression of AF (RACE V). Grant support to the institution from Medtronic, Abbott outside submitted work. Funding information: The AF-RISK study was funded by the Dutch Heart Foundation ( NHS2010B233 ). This project received funding from European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie [agreement 754425 ], the Dutch Heart Foundation (grant 2015T082 to J.L.) and the Netherlands Organisation for Scientific Research (NWO- ZonMw, grant 016.176.340 to J.L.).

Publisher Copyright:
© 2022 The Author(s)

ID: 313883056